Vaccine | Euronews

English

United Kingdom

UK government secures 90 million coronavirus vaccine doses

There are three candidate vaccines for which the UK has secured early access.

Brazil

COVID-19: Footvolley returns to Rio as Australia suspends parliament

Meanwhile, US infections are close to hit the four million mark.

USA

‘This is good news’: US hails results from coronavirus vaccine trial

After results of a COVID-19 vaccine trial were released, Dr Fauci, the US government’s top infectious disease expert, said: “No matter how you slice this, this is good news.”

USA

Novavax receives $1.6 billion from US government for 100m vaccines

NVX‑CoV2373 is the name of the company's COVID-19 vaccine candidate.

ADVERTISEMENT

Smart Regions

Project harnesses data from 11 EU countries to help beat COVID-19

In partnership with the European Commission

Smart Regions takes a look at one EU project that's strengthening the epidemiological and virological surveillance of COVID-19 by harnessing patient data from 11 European countries.

World News

Coronavirus vaccine: European countries strike deal with pharma giant

If the University of Oxford approves a coronavirus vaccine that is currently testing, the EU will be provided with at least 300 million doses.

United Kingdom

Global Vaccine Summit seeks to coordinate COVID-19 inoculation drive

A global summit aims to raise $7.4 billion for vaccine programmes for the years to come - with a focus on organising a future coronavirus vaccine

Next Series

Powerful properties: how tobacco is being used to fight COVID-19

In partnership with The European Commission

Futuris takes a look at how scientists in Spain are using tobacco and molecular farming to help create tailor-made vaccines and antibodies.

United Kingdom

Thousands of people to take part in Oxford vaccine's new trial phase

The University of Oxford has said it is ready to begin its second and third phase of clinical testing a possible vaccine for coronavirus.

Next Series

Engineering bacteria to defeat disease

In partnership with The European Commission

Futuris investigates how scientists are treating respiratory disease with synthetic vaccines developed from bacteria. It's hoped the research could eventually help in the fight against COVID-19.

World News

At least 18 months before COVID-19 vaccine available: French minister

France's research minister said that it would take at least 18 months to get a coronavirus vaccine after US President Donald Trump said there would be a vaccine by the end of the year.

USA

US looking to get COVID-19 vaccine 'by year end', says Trump

The US President said the country is pouring resources into expediting vaccine trials and getting ready to quickly produce and distribute the vaccine once it's been developed.

France

French pharma giant irks Paris with US first for vaccine comment

Edouard Philippe, France's prime minister, said "equal access for everyone to the vaccine is not negotiable". It came after French pharma giant Sanofi suggested the US would be first in line for any cure.

World News

Coronavirus: Experts answer your burning COVID-19 questions

Every week on Euronews, we're bringing together a panel of leading experts in a variety of fields to answer your coronavirus questions.

World News

Analysis: The search for a COVID-19 vaccine

We might get lucky with a vaccine, our political editor writes, but at the moment it’s the stark and worrying prediction from the UK's Chief Medical Officer that could be the path that we are all forced to follow - two metres apart, of course.

World News

COVID-19: Vaccine trials begin in Europe, warnings over other diseases

As coronavirus vaccine trials begin in the UK and get the green light in Germany, the World Health Organization warns other diseases must not be neglected.

United Kingdom

Coronavirus: 'UK to begin testing vaccine on humans this week'

The UK's health minister Matt Hancock said human trials for a COVID-19 vaccine would begin this week.

World News

Pharma giants GSK and Sanofi team up to find coronavirus vaccine

The pharma giants are hoping their scale will allow them to make a vaccine widely available by the second half of 2021.

World News

Euroviews. Rising populism stokes discontent but offers few solutions to global threats like COVID-19 ǀ View

Global problems, like the current COVID-19 crisis and the climate emergency, do not respect borders. Solutions to these issues are most likely to come when people coordinate their efforts across sectors, cultures and national boundaries, and not succumb to the short-sightedness views of populism.

My Europe Series

Where are we with COVID-19 vaccines and treatments?

With over a million people already infected and 50,000 fatalities, the race is on to find a cure for COVID-19, the virus which has arguably caused the most serious global crisis since World War II.